Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma in the Era of New Drugs and CAR-T Cell Therapy

Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma in the Era of New Drugs and CAR-T Cell Therapy

MCL is an uncommon lymphoproliferative disorder that has been regarded as incurable since its identification as a distinct entity. Allogeneic transplantation for two decades has represented the only option capable of ensuring prolonged remissions and possibly cure. Despite its efficacy, its applicat...

Full description

Bibliographic Details
Main Authors: Miriam Marangon, Carlo Visco, Anna Maria Barbui, Annalisa Chiappella, Alberto Fabbri, Simone Ferrero, Sara Galimberti, Stefano Luminari, Gerardo Musuraca, Alessandro Re, Vittorio Ruggero Zilioli, Marco Ladetto
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Cancers
Subjects:
mantle cell lymphoma
allogeneic stem cell transplantation
Car-T cell therapy
Online Access:https://www.mdpi.com/2072-6694/13/2/291

Internet

https://www.mdpi.com/2072-6694/13/2/291

Similar Items